ZA200106413B - T Helper cell epitopes. - Google Patents
T Helper cell epitopes.Info
- Publication number
- ZA200106413B ZA200106413B ZA200106413A ZA200106413A ZA200106413B ZA 200106413 B ZA200106413 B ZA 200106413B ZA 200106413 A ZA200106413 A ZA 200106413A ZA 200106413 A ZA200106413 A ZA 200106413A ZA 200106413 B ZA200106413 B ZA 200106413B
- Authority
- ZA
- South Africa
- Prior art keywords
- epitopes
- helper cell
- cell epitopes
- sgrrqrrfagvvlagva
- fagvvlagvalgvataa
- Prior art date
Links
- 210000002443 helper t lymphocyte Anatomy 0.000 title abstract 2
- 230000028993 immune response Effects 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
- C12N2760/18422—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Detergent Compositions (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Luminescent Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPP8533A AUPP853399A0 (en) | 1999-02-05 | 1999-02-05 | T helper cell epitopes |
AUPQ2013A AUPQ201399A0 (en) | 1999-08-04 | 1999-08-04 | T-helper cell epitopes |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200106413B true ZA200106413B (en) | 2002-08-05 |
Family
ID=25645983
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200106413A ZA200106413B (en) | 1999-02-05 | 2001-08-03 | T Helper cell epitopes. |
Country Status (15)
Country | Link |
---|---|
US (5) | US6685947B1 (el) |
EP (2) | EP1147212B1 (el) |
JP (2) | JP4699612B2 (el) |
KR (2) | KR100955668B1 (el) |
AT (1) | ATE440960T1 (el) |
AU (1) | AU765164B2 (el) |
CA (1) | CA2361658C (el) |
CY (1) | CY1109710T1 (el) |
DE (1) | DE60042816D1 (el) |
DK (1) | DK1147212T3 (el) |
ES (1) | ES2332701T3 (el) |
NZ (1) | NZ513482A (el) |
PT (1) | PT1147212E (el) |
WO (1) | WO2000046390A1 (el) |
ZA (1) | ZA200106413B (el) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2361658C (en) * | 1999-02-05 | 2013-04-09 | The University Of Melbourne | T helper cell epitopes |
US20050106137A1 (en) * | 2000-05-05 | 2005-05-19 | Stephen Grimes | Chimeric peptide immunogens |
AU2002249895A1 (en) * | 2001-01-05 | 2002-07-16 | Joslin Diabetes Center, Inc. | Autoantigen composition |
CA2494193A1 (en) | 2002-08-12 | 2004-02-19 | The Council Of The Queensland Institute Of Medical Research | Novel immunogenic lipopeptides comprising t-helper and cytotoxic t lymphocyte (ctl) epitopes |
EP1543039B1 (en) | 2002-08-12 | 2011-07-13 | The Council Of The Queensland Institute Of Medical Research | Novel immunogenic lipopeptides comprising t-helper and b-cell epitopes |
US7178491B2 (en) * | 2003-06-05 | 2007-02-20 | Caterpillar Inc | Control system and method for engine valve actuator |
US8202841B2 (en) | 2004-06-17 | 2012-06-19 | Mannkind Corporation | SSX-2 peptide analogs |
AU2005282231B2 (en) * | 2004-09-10 | 2011-03-10 | The Council Of The Queensland Institute Of Medical Research (Qimr) | Truncated LHRH formulations |
CN101084239A (zh) * | 2004-09-10 | 2007-12-05 | 昆士兰医学研究所理事会(Qimr) | 截短的lhrh制剂 |
AU2006236294A1 (en) | 2005-04-19 | 2006-10-26 | Eli Lilly And Company | Monovalent and polyvalent synthetic polysaccharide antigens for immunological intervention in disease |
CA2609244A1 (en) * | 2005-06-01 | 2006-12-07 | Pfizer Products Inc. | Vaccine compositions and methods for the treatment of urinary incontinence |
ES2413079T3 (es) | 2005-06-17 | 2013-07-15 | Mannkind Corporation | Métodos y composiciones para desencadenar respuestas inmunitarias multivalentes contra epítopos dominantes y subdominantes expresados en células cancerosas y estroma tumoral |
AU2006259307B2 (en) * | 2005-06-17 | 2012-12-20 | Mannkind Corporation | Epitope analogues |
WO2007127787A2 (en) * | 2006-04-25 | 2007-11-08 | Joslin Diabetes Center, Inc. | Insulin autoantigen-specific regulatory cd4+ t cells |
CO2021017322A1 (es) * | 2021-12-16 | 2023-06-20 | Univ Cooperativa De Colombia | Péptidos inmunogénicos contra el virus distemper canino (cdv) |
CN115960262A (zh) * | 2022-10-19 | 2023-04-14 | 四川农业大学 | 展示cdv抗原表位的犬细小病毒样颗粒及构建方法和应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5047238A (en) | 1983-06-15 | 1991-09-10 | American Home Products Corporation | Adjuvants for vaccines |
US6309647B1 (en) * | 1999-07-15 | 2001-10-30 | Aventis Pasteur | Poxvirus—canine dispemper virus (CDV) or measles virus recombinants and compositions and methods employing the recombinants |
US5756102A (en) * | 1990-11-20 | 1998-05-26 | Virogenetics Corporation | Poxvirus-canine distemper virus (CDV) recombinants and compositions and methods employing the recombinants |
JP2001513120A (ja) | 1997-02-11 | 2001-08-28 | ザ カウンシル オブ ザ クイーンズランド インスティチュート オブ メディカル リサーチ | ペプチドを含むポリマー |
CA2361658C (en) * | 1999-02-05 | 2013-04-09 | The University Of Melbourne | T helper cell epitopes |
-
2000
- 2000-02-07 CA CA2361658A patent/CA2361658C/en not_active Expired - Fee Related
- 2000-02-07 AT AT00906047T patent/ATE440960T1/de active
- 2000-02-07 KR KR1020087023328A patent/KR100955668B1/ko not_active IP Right Cessation
- 2000-02-07 PT PT00906047T patent/PT1147212E/pt unknown
- 2000-02-07 AU AU27836/00A patent/AU765164B2/en not_active Ceased
- 2000-02-07 DK DK00906047T patent/DK1147212T3/da active
- 2000-02-07 US US09/890,650 patent/US6685947B1/en not_active Expired - Fee Related
- 2000-02-07 KR KR1020017009925A patent/KR100905264B1/ko not_active IP Right Cessation
- 2000-02-07 NZ NZ513482A patent/NZ513482A/en not_active IP Right Cessation
- 2000-02-07 JP JP2000597449A patent/JP4699612B2/ja not_active Expired - Fee Related
- 2000-02-07 WO PCT/AU2000/000070 patent/WO2000046390A1/en active IP Right Grant
- 2000-02-07 EP EP00906047A patent/EP1147212B1/en not_active Expired - Lifetime
- 2000-02-07 EP EP09002189A patent/EP2103691A1/en not_active Withdrawn
- 2000-02-07 DE DE60042816T patent/DE60042816D1/de not_active Expired - Lifetime
- 2000-02-07 ES ES00906047T patent/ES2332701T3/es not_active Expired - Lifetime
-
2001
- 2001-08-03 ZA ZA200106413A patent/ZA200106413B/xx unknown
-
2003
- 2003-11-13 US US10/705,819 patent/US7097844B2/en not_active Expired - Fee Related
-
2004
- 2004-09-08 US US10/935,155 patent/US7037507B2/en not_active Expired - Fee Related
-
2006
- 2006-05-04 US US11/417,131 patent/US7241448B2/en not_active Expired - Fee Related
-
2007
- 2007-06-19 US US11/812,458 patent/US7572454B2/en not_active Expired - Fee Related
-
2009
- 2009-11-26 CY CY20091101243T patent/CY1109710T1/el unknown
-
2011
- 2011-01-26 JP JP2011013646A patent/JP2011121965A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2011121965A (ja) | 2011-06-23 |
EP1147212B1 (en) | 2009-08-26 |
EP1147212A1 (en) | 2001-10-24 |
US7037507B2 (en) | 2006-05-02 |
EP1147212A4 (en) | 2004-03-31 |
US20050186220A1 (en) | 2005-08-25 |
JP4699612B2 (ja) | 2011-06-15 |
CY1109710T1 (el) | 2014-08-13 |
JP2002536384A (ja) | 2002-10-29 |
ES2332701T3 (es) | 2010-02-11 |
US20050037014A1 (en) | 2005-02-17 |
KR20090015892A (ko) | 2009-02-12 |
CA2361658A1 (en) | 2000-08-10 |
US7097844B2 (en) | 2006-08-29 |
KR20010101796A (ko) | 2001-11-14 |
KR100905264B1 (ko) | 2009-06-29 |
CA2361658C (en) | 2013-04-09 |
KR100955668B1 (ko) | 2010-05-06 |
US20060199177A1 (en) | 2006-09-07 |
US6685947B1 (en) | 2004-02-03 |
DK1147212T3 (da) | 2010-01-04 |
US20070248615A1 (en) | 2007-10-25 |
DE60042816D1 (de) | 2009-10-08 |
PT1147212E (pt) | 2009-12-03 |
US7572454B2 (en) | 2009-08-11 |
US7241448B2 (en) | 2007-07-10 |
AU2783600A (en) | 2000-08-25 |
EP2103691A1 (en) | 2009-09-23 |
NZ513482A (en) | 2003-08-29 |
ATE440960T1 (de) | 2009-09-15 |
AU765164B2 (en) | 2003-09-11 |
WO2000046390A1 (en) | 2000-08-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200106413B (en) | T Helper cell epitopes. | |
TR199900267T2 (xx) | GnRH-L�kotoksin kimeralar�. | |
NZ508366A (en) | Neisseria meningitidis antigens and compositions | |
HU230007B1 (en) | Antigenic peptides derived from telomerase | |
NO20002800D0 (no) | Cyklosporinholdig mikroemulsjon, forkonsentratsammensetning | |
WO2002053180A3 (en) | Immunizing compositions and methods of use | |
ZA976815B (en) | Vaccine composition. | |
CA2185541A1 (en) | Cytotoxic t-cell epitopes | |
MXPA03010684A (es) | Peptidos y el uso de los mismos para oscurecer la piel. | |
NO910982D0 (no) | Uratoksydase-aktivt protein, rekombinant gen som koder for det, ekspresjonsvektor, mikroorganismer og transformerteceller. | |
ZA9811276B (en) | Non-whitening underarm compositions. | |
AU5892399A (en) | 1, 2, 4-triazole-3-thione compounds | |
DE69426121D1 (de) | Gen grb3-3, variante und ihre verwendungen | |
IL139604A0 (en) | Novel peptides | |
ZA985135B (en) | Plant grab proteins. | |
HUP9802587A3 (en) | Glucose-inducible recombinant viral vector, pharmaceutical composition containing it and cells transformed by this | |
ATE372787T1 (de) | Atelocollagen enthaltende gen-zusammensetzungen | |
SG185137A1 (en) | Biologically active peptides | |
WO2001011937A3 (en) | Use of colostrinin, constituent peptides thereof, and analogs thereof for inducing cytokines | |
ZA992262B (en) | Vectors for transferring nucleic acids, compositions containing them and their uses. | |
ZA978477B (en) | Cysteine containing peptides. | |
Reinhart | The regime of lies | |
PL343000A1 (en) | Novel sequence class of genes, corresponding proteins and the use of the same | |
ZA984474B (en) | Hairspray compositions containing silicone block copolymers | |
Hwang et al. | Involvement of Oxygen Radicals in the Low-Temperature Photoinhibition of Photosystem I |